A red rectangle at the top of the page with a white icon of a calendar with a clock and text that says PDAB public comments are due on Monday Oct, 13 at 8 am! Below is a light blue icon of a paper with a dollar sign and a down arrow. White background with black text says The Oregon Prescription Drug Affordability Board (PDAB) is reviewing high-cost drugs to determine if they strain Oregon patients or our healthcare system at their October 15 meeting. If you or someone you know has paid a high price for any of these Insulin Glargine products: Basaglar KwikPen Insulin Glargine-yfgn Lantus Lantus SoloStar Semglee (yfgn) Toujeo Max SoloStar Toujeo SoloStar Consider sharing you experience with the Oregon PDAB at the link. A teal arrow points to the right. An icon of an internet search bar with red text that says: bit.ly/or-pdab-comment
Pale pink background, title reads" TIPS FOR PDAB PUBLIC TESTIMONY" Start with your name and where you live Example: “Hello, my name is Jamie Lee and I live in Eugene.” Name the prescription drug you're speaking about Example: “I’m here to talk about the cost of Humira.” Explain your coverage (if any) Example: “I have private insurance, but I still pay over $300 a month.” Share how the cost impacts you Example: “I sometimes skip doses to stretch out my prescription because I can't afford to refill it on time.” Ask the board to act and say thank you Example: “Please consider how the cost affects real people like me. Thank you.”
Reminder to submit public comment to the next #Oregon Prescription Drug Affordability Board (#PDAB) meeting before Monday at 8 am! Link to submit comments: bit.ly/or-pdab-comment
#BasaglarKwikPen #InsulinGlargineyfgn #Lantus #LantusSoloStar #Semgleeyfgn #ToujeoMaxSoloStar #ToujeoSoloStar
